Liquidia Technologies, Inc. (NASDAQ:LQDA) Shares Purchased by GAMMA Investing LLC

GAMMA Investing LLC grew its stake in shares of Liquidia Technologies, Inc. (NASDAQ:LQDA - Free Report) by 2,342.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 43,675 shares of the company's stock after acquiring an additional 41,887 shares during the period. GAMMA Investing LLC owned about 0.05% of Liquidia Technologies worth $644,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of LQDA. Cetera Investment Advisers raised its position in shares of Liquidia Technologies by 4.3% during the 4th quarter. Cetera Investment Advisers now owns 31,243 shares of the company's stock worth $367,000 after purchasing an additional 1,277 shares during the last quarter. Deutsche Bank AG raised its position in shares of Liquidia Technologies by 53.4% during the 4th quarter. Deutsche Bank AG now owns 51,075 shares of the company's stock worth $601,000 after purchasing an additional 17,790 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Liquidia Technologies during the 4th quarter worth approximately $218,000. Millennium Management LLC acquired a new position in shares of Liquidia Technologies during the 4th quarter worth approximately $526,000. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Liquidia Technologies by 9.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 428,570 shares of the company's stock worth $5,040,000 after purchasing an additional 38,313 shares during the last quarter. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on LQDA. Oppenheimer set a $13.00 price objective on Liquidia Technologies and gave the stock an "underperform" rating in a research report on Monday, May 19th. Wall Street Zen upgraded Liquidia Technologies from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. BTIG Research restated a "buy" rating on shares of Liquidia Technologies in a research report on Tuesday, May 27th. Bank of America cut their price objective on Liquidia Technologies from $25.00 to $23.00 and set a "buy" rating for the company in a research report on Wednesday, June 11th. Finally, Wells Fargo & Company lifted their price objective on Liquidia Technologies from $23.00 to $25.00 and gave the stock an "overweight" rating in a research report on Thursday, June 12th. One analyst has rated the stock with a sell rating, one has issued a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $26.89.

Liquidia Technologies Trading Down 3.4%

Shares of Liquidia Technologies stock traded down $0.47 during trading hours on Friday, reaching $13.17. 1,905,125 shares of the company's stock were exchanged, compared to its average volume of 1,216,406. Liquidia Technologies, Inc. has a 52-week low of $8.26 and a 52-week high of $19.41. The firm has a market capitalization of $1.13 billion, a price-to-earnings ratio of -8.34 and a beta of 0.04. The company has a fifty day moving average of $15.26 and a 200-day moving average of $14.24. The company has a current ratio of 2.93, a quick ratio of 2.91 and a debt-to-equity ratio of 2.08.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). The business had revenue of $3.12 million for the quarter, compared to analysts' expectations of $3.23 million. Liquidia Technologies had a negative return on equity of 177.91% and a negative net margin of 903.80%. Sell-side analysts forecast that Liquidia Technologies, Inc. will post -1.51 EPS for the current fiscal year.

Insider Transactions at Liquidia Technologies

In other news, CEO Roger Jeffs sold 14,130 shares of the company's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $13.57, for a total transaction of $191,744.10. Following the completion of the sale, the chief executive officer now directly owns 1,006,420 shares in the company, valued at $13,657,119.40. This represents a 1.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Rajeev Saggar sold 2,450 shares of the company's stock in a transaction on Monday, April 21st. The stock was sold at an average price of $13.67, for a total value of $33,491.50. Following the sale, the insider now owns 263,152 shares of the company's stock, valued at approximately $3,597,287.84. The trade was a 0.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,138 shares of company stock worth $450,233 in the last ninety days. Insiders own 30.10% of the company's stock.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).